Back to MW MARSHALL WACE, LLP

HRTXHRTX
Showing 7 of 13 quarters

Position history for MWMARSHALL WACE, LLP's holdings in HERON THERAPEUTICS INC

MARSHALL WACE, LLP holds 2.4M shares of HRTX (HERON THERAPEUTICS INC), worth $1M as of 2026-Q2. This is a new position. HRTX represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$1M

Current Shares

2.4M

Total Value Change

-$2.4M

Total Shares Change

+638,648

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
2.4M
-
$1M0.0%$0.43
35
2025-Q4
Exited
0
-100.0%
$00.0%$1.35
0
2025-Q3
Decreased
1.3M
-54.8%
$1.6M0.0%$1.27
0
2025-Q2
Increased
2.9M
+130.7%
$6M0.0%$2.14
44
2025-Q1
Increased
1.3M
+23.3%
$2.8M0.0%$2.26
32
2024-Q4
Decreased
1M
-40.7%
$1.6M0.0%$1.51
0
2024-Q3
Decreased
1.7M
-2.6%
$3.4M0.0%$1.99
0

Other major holders of HRTX: FRANKLIN RESOURCES INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used